检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Application of the keynote-564 trial results to real life population: which patients with advanced kidney cancer should receive adjuvant pembrolizumab

G. Fallara,G. Rosiello,D. Raggi,L. Marandino,G. Malena,G. Basile,G. Colandrea,D. Cignoli,F. Belladelli,G. Musso,F. Cei,R. Bertini,A. Briganti,A. Salonia,F. Montorsi,A. Larcher,A. Necchi,U. Capitanio

European Urology Open Science（2022）

引用 0|浏览8
暂无评分
关键词
adjuvant pembrolizumab,advanced kidney cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要